Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Pharmacokinetics and in vivo distribution of optimized PLGA nanoparticles for pulmonary delivery of levofloxacin

Title: Pharmacokinetics and in vivo distribution of optimized PLGA nanoparticles for pulmonary delivery of levofloxacin
Authors: Shah, Sunny R; Prajapati, Hani R; Sheth, Devang B; Gondaliya, Ekta M; Vyas, Amit J; Soniwala, Moinuddin M; Chavda, Jayant R
Contributors: Gujarat Council of Science and Technology
Source: Journal of Pharmacy and Pharmacology ; volume 72, issue 8, page 1026-1037 ; ISSN 2042-7158 0022-3573
Publisher Information: Oxford University Press (OUP)
Publication Year: 2020
Description: Objectives The aim of this study was to develop and optimize levofloxacin loaded PLGA nanoparticles (LN) for pulmonary delivery employing screening and experimental design and evaluate their in-vitro and in-vivo performance. The objective was to achieve Mass Median Aerodynamic Diameter (MMAD) of LN of less than 5μm, sustain the drug release up to 120 h and a higher AUC/MIC at the site of action. Methods LN were prepared by modified emulsion solvent evaporation technique employing high speed homogenization, probe sonication and subsequent lyophilization. Key Findings The Pareto chart from Placket Burman screening design revealed that homogenization speed and amount of PLGA were found to be significant (P < 0.05). Further analysis by 3 full-factorial design revealed that F-ratio was found to be far greater than the theoretical value (P < 0.05) for each regression model. Conclusion The optimized formulation with desirability value 0.9612 showed mean particle size of 146 nm, MMAD of 4.40 μm and sustained the drug release up to 120 h in simulated lung fluid. Augmentation in Cmax (1.71-fold), AUC 0-∞ (5.46-fold), Mean Residence Time (6.64-fold) and AUC/MIC (6.21-fold) of LN through pulmonary route was found to significantly higher (P < 0.05) than levofloxacin (p. o.).
Document Type: article in journal/newspaper
Language: English
DOI: 10.1111/jphp.13275
Availability: https://doi.org/10.1111/jphp.13275; https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fjphp.13275; https://onlinelibrary.wiley.com/doi/pdf/10.1111/jphp.13275; https://onlinelibrary.wiley.com/doi/full-xml/10.1111/jphp.13275; https://academic.oup.com/jpp/article-pdf/72/8/1026/60226600/jphp13275.pdf
Rights: https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model
Accession Number: edsbas.B61DFE62
Database: BASE